|
Schlusskurs
Korea S.E.
|
||
| - KRW | - |
|
| 25.08. | Celltrion bringt Omlyclo in der Wirkstärke 300 mg in wichtigen europäischen Märkten auf den Markt | CI |
| 24.08. | Celltrion reicht Zulassungsantrag für Keytruda-Biosimilar in Südkorea ein | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.10% | -0.95% | +4.71% | +16.81% | +9.07% | +2.98% | +23.36% | -24.39% | +214.36% | 51.14 Mrd. | |
| +2.65% | +4.45% | +17.59% | +44.54% | +177.65% | +481.36% | +567.32% | +675.69% | - | 47.4 Mrd. | |
| +0.33% | +2.47% | +23.06% | +58.42% | +16.40% | +38.97% | +19.80% | +1.09% | +246.65% | 43.19 Mrd. | |
| -0.88% | +0.90% | +14.30% | +24.16% | +22.61% | +24.11% | +87.74% | +32.10% | +1’230.80% | 42.35 Mrd. | |
| -2.27% | -3.02% | +6.76% | +0.19% | +9.99% | +14.22% | +51.50% | -18.22% | +145.06% | 33.23 Mrd. | |
| -1.21% | -0.17% | +3.77% | +42.89% | +8.89% | +29.16% | +135.38% | +238.56% | +2’154.22% | 17.07 Mrd. | |
| -0.36% | -2.14% | -1.60% | +5.99% | - | - | - | - | - | 16.38 Mrd. | |
| -0.52% | -0.30% | +5.98% | +17.58% | +16.38% | +12.00% | +28.21% | -39.56% | +97.79% | 14.76 Mrd. | |
| +0.44% | +1.70% | +32.15% | +80.20% | +48.59% | +82.07% | +47.92% | -32.13% | +256.65% | 14.15 Mrd. | |
| +0.47% | -2.61% | +0.56% | +43.28% | -6.86% | -2.46% | -33.79% | -33.10% | +125.42% | 13.09 Mrd. | |
| +3.23% | +6.06% | +64.74% | +49.86% | +19.71% | -3.47% | - | - | - | 12.75 Mrd. | |
| +0.12% | +0.26% | +1.19% | +50.70% | +23.23% | +28.90% | -9.59% | -41.44% | +174.30% | 11.36 Mrd. | |
| +3.48% | -9.25% | +20.48% | +79.99% | +63.28% | +45.88% | +63.80% | -46.57% | - | 11.29 Mrd. | |
| -1.30% | -3.09% | -9.33% | -13.08% | -18.06% | +43.60% | +456.72% | +219.26% | +2’311.98% | 10.89 Mrd. | |
| -2.52% | +0.90% | +16.48% | +3.00% | +24.80% | +683.99% | +1’534.89% | +23.61% | - | 10.27 Mrd. | |
| -1.47% | +6.25% | +11.56% | -18.38% | -21.08% | +46.04% | +54.84% | +57.53% | +102.04% | 10.37 Mrd. | |
| -4.24% | -1.05% | +9.25% | +47.16% | +54.52% | +184.50% | +512.17% | +99.52% | - | 10 Mrd. | |
| +0.01% | +0.16% | +0.51% | +73.58% | +78.80% | +257.13% | +468.25% | - | - | 10.18 Mrd. | |
| -1.30% | +1.68% | +108.33% | +150.86% | +181.96% | +106.24% | +88.28% | -6.24% | +1’616.67% | 9.9 Mrd. | |
| Durchschnitt | -0.47% | +0.92% | +17.39% | +39.88% | +39.44% | +115.29% | +240.99% | +69.11% | +723.00% | 20.52 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.19% | +1.07% | +15.18% | +35.51% | +43.09% | +113.13% | +194.12% | +106.56% | +612.41% |
- Börse
- Aktien
- A068270 Aktie
- 068270 Aktie
- Sektor Celltrion, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
